Summary
The product Ciamed 5, manufactured by Deus Medical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number DM44568, was submitted by the reseller DEUSPOWER.COM and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Tadalafil, with measured concentrations of 4.86 mg in the first pill and 4.99 mg in the second pill, closely matching the labeled claim of 5 mg per pill.
The testing process began on 12 June 2020, with the sample received the same day and analysis completed on 13 June 2020. While the results confirm accurate dosing, scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Ciamed 5
- Active Ingredient: Tadalafil
- Batch Number: DM44568
- Expiration Date: Not provided
- Delivery Method: Oral (pill)
Sample Acquisition and Testing
- Task Number: #06810
- Testing Ordered: 12 June 2020
- Sample Received: 12 June 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.COM (Reseller)
- Analysis Paid For By: DEUSPOWER.COM
Testing Results
- Specification: 5 mg per pill (as stated on the label)
- Measured Concentration:
- First Pill: 4.86 mg
- Second Pill: 4.99 mg
- Accuracy: Within an acceptable range of the labeled claim
Verification Details
- Verification URL: https://janoshik.com/tests/06810_25K9YG2SWZVH
Evaluation of Reseller-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller DEUSPOWER.COM. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Ciamed 5 (Tadalafil 5 mg/pill) is accurately dosed, with measured concentrations of 4.86 mg and 4.99 mg per pill. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
